Literature DB >> 29171395

Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.

Martina Maurelli1, Gianpaolo Tessari1, Chiara Colato2, Donatella Schena1, Giampiero Girolomoni1.   

Abstract

BACKGROUND: Primary cutaneous lymphomas (PCLs) are a rare group of extranodal non-Hodgkin lymphomas, and epidemiological data in Mediterranean countries are scarce.
OBJECTIVE: To investigate the incidence and characteristics of PCL in a single tertiary referral centre in Italy. MATERIALS &
METHODS: A total of 141 PCL patients, seen over a 10-year follow-up period, were investigated.
RESULTS: Incidence rate of PCL was 0.8 cases/100,000 person years. T-cell lymphoma represented 78.7% of all cases, the majority being early mycosis fungoides (MF) (64%; median age: 66 years), followed by lymphomatoid papulosis (LyP) (19%; median: age 48 years), and others (median age: 72 years), including eight cases of anaplastic large CD30+ T-cell lymphoma, four CD4+ small-medium pleomorphic T-cell lymphoproliferative disorder, four Sézary syndrome, one subcutaneous panniculitis-like T-cell lymphoma, one extranodal NK/T-cell lymphoma nasal-type, and one angioimmunoblastic T-cell lymphoma. B-cell lymphoma accounted for 21.3% of PCL, with 20 cases of cutaneous follicular centre B-cell (median age: 63 years), four primary cutaneous marginal zone, three primary cutaneous diffuse large B-cell, and three leg-type lymphoma. Complete remission within the first year after diagnosis occurred in 70.4% of MF, 61.9% of LyP, 78.9% of other T-cell lymphoma, and 93.1% of B-cell lymphoma cases. Based on a Cox proportional hazard regression model, age, gender, stage, and lactate dehydrogenase and β2-microglobulin blood levels did not predict clinical remission of MF or LyP.
CONCLUSIONS: The incidence and characteristics of PCL in Italy are similar to those in other European countries. PCLs may be diagnosed at very early stages with good prognosis.

Entities:  

Keywords:  cutaneous lymphoma; diagnosis; prevalence

Mesh:

Year:  2018        PMID: 29171395     DOI: 10.1684/ejd.2017.3183

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  Immunomodulation in Cutaneous T Cell Lymphoma.

Authors:  Martina Ferranti; Giulia Tadiotto Cicogna; Irene Russo; Mauro Alaibac
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

2.  Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.

Authors:  Chutipon Pruksaeakanan; Phurichaya Teyateeti; Poramin Patthamalai; Janista Thumrongtharadol; Manasmon Chairatchaneeboon
Journal:  Biomed Res Int       Date:  2021-06-11       Impact factor: 3.411

Review 3.  Pruritus as a Distinctive Feature of Type 2 Inflammation.

Authors:  Simone Garcovich; Martina Maurelli; Paolo Gisondi; Ketty Peris; Gil Yosipovitch; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2021-03-23

4.  Non-Melanoma Skin Cancer Mortality in Spain: A Predictive Model up to 2044.

Authors:  Mercedes Sendín-Martin; Juan Carlos Hernández-Rodríguez; Antonio-José Durán-Romero; Juan Ortiz-Álvarez; Julian Conejo-Mir; José-Juan Pereyra-Rodríguez
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.